Regarding LIMD1, it has been identified in colorectal cancer that its expression correlates with MDR, and it has also been established that its negative regulation can reverse drug resistance in multidrug-resistant cells of the same type of cancer [44]. This evidence concerns the gene LIMD1 and colorectal cancer.